Search - tctmd.com

Displaying 641 - 660 of 1134

Sort: Relevancy | Date

News Industry News

FDA Approves Aortica Corporation to Supply AortaFit™ System for Starnes' Physician-Sponsored IDE Study

January 27, 2016

News Opinion Fellow Talk

Test Your Knowledge: 10 Essential Questions on the Evolution of Interventional Cardiology

Sarah Elsayed, MD

January 25, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular News Stories for 2015

Shelley Wood

December 29, 2015

News Industry News

Isis Pharmaceuticals Announces Initiation of an Investigator-Sponsored Phase 2 Study of ISIS-TTR Rx in Patients with TTR Cardiomyopathy Amyloidosis

December 16, 2015

News Daily News

US Government Mulls Changes to Rules for Research in Humans

Caitlin E. Cox

December 13, 2015

News Daily News

Years Later, MIST Trial Investigator Suspended in Long-Running Controversy Over PFO-Closure Study Misconduct

Shelley Wood

December 03, 2015

News Daily News

It’s Official: Europe Bans Direct Industry Sponsorship of Physicians for CME

Todd Neale

December 02, 2015

News Conference News AHA 2015

RIVER-PCI Subanalysis: No Impact of Ranolazine on Quality of Life

L.A. McKeown

November 09, 2015

News Conference News AHA 2015

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

Shelley Wood

November 05, 2015

News Industry News

REALITY Study to Evaluate Use of Directional Atherectomy and Drug Coated Balloon in Patients with Peripheral Arterial Disease

November 02, 2015

News Daily News

NEJM支持 Robert Califf担任FDA局长

L.A. McKeown

October 30, 2015

News Daily News

NEJM Endorses Robert Califf for FDA Commissioner

L.A. McKeown

October 30, 2015

News Daily News

NEJM Apoya a Robert Califf como Comisionado de la FDA

L.A. McKeown

October 30, 2015

News Daily News

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

L.A. McKeown

October 26, 2015

News Daily News

Goodbye BMS? New DAPT Analysis Shows Less Stent Thrombosis With DES

Yael L. Maxwell

October 26, 2015

Presentation TCT 2015

New Noninvasive Methods for Assessing Valvular Heart Disease

Presenter: Jeroen J. Bax, Paul A. Grayburn

October 15, 2015

Presentation TCT 2015

Debate 2: BVS Is a Revolutionary Breakthrough, Not an Expensive Gimmick. I'm Against the Proposal!

Presenter: Andreas Baumbach, Simon Redwood, Adrian P. Banning

October 15, 2015

Presentation TCT 2015

Debate 2: BVS Is a Revolutionary Breakthrough, Not an Expensive Gimmick. I'm for the Proposal!

Presenter: Andreas Baumbach, Simon Redwood, Nick E. J. West

October 15, 2015

Presentation TCT 2015

Assessing Postdevice Paravalvular Aortic Regurgitation

Presenter: Jeroen J. Bax, Paul A. Grayburn, Rebecca T. Hahn

October 15, 2015

Presentation TCT 2015

What Defines Severe MR Post-AHA/ACC Guidelines?

Presenter: Jeroen J. Bax, Paul A. Grayburn

October 15, 2015

Advertisement

FDA Approves Aortica Corporation to Supply AortaFit™ System for Starnes' Physician-Sponsored IDE Study

Test Your Knowledge: 10 Essential Questions on the Evolution of Interventional Cardiology

TCTMD’s Top 10 Most Popular News Stories for 2015

Isis Pharmaceuticals Announces Initiation of an Investigator-Sponsored Phase 2 Study of ISIS-TTR Rx in Patients with TTR Cardiomyopathy Amyloidosis

US Government Mulls Changes to Rules for Research in Humans

Years Later, MIST Trial Investigator Suspended in Long-Running Controversy Over PFO-Closure Study Misconduct

It’s Official: Europe Bans Direct Industry Sponsorship of Physicians for CME

RIVER-PCI Subanalysis: No Impact of Ranolazine on Quality of Life

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

REALITY Study to Evaluate Use of Directional Atherectomy and Drug Coated Balloon in Patients with Peripheral Arterial Disease

NEJM支持 Robert Califf担任FDA局长

NEJM Endorses Robert Califf for FDA Commissioner

NEJM Apoya a Robert Califf como Comisionado de la FDA

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

Goodbye BMS? New DAPT Analysis Shows Less Stent Thrombosis With DES

New Noninvasive Methods for Assessing Valvular Heart Disease

Debate 2: BVS Is a Revolutionary Breakthrough, Not an Expensive Gimmick. I'm Against the Proposal!

Debate 2: BVS Is a Revolutionary Breakthrough, Not an Expensive Gimmick. I'm for the Proposal!

Assessing Postdevice Paravalvular Aortic Regurgitation

What Defines Severe MR Post-AHA/ACC Guidelines?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content